Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of CoronaVac in Indonesian Adults
NCT04508075Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Bio Farma. Started Aug 2020; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04508075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04508075.